Xiao-Jun Zhu
Overview
Explore the profile of Xiao-Jun Zhu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
147
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Xue H, Chen P, Zhu X, Jiao J, Wang P
World J Clin Oncol
. 2024 Oct;
15(10):1366-1375.
PMID: 39473856
Background: Robotic-assisted partial splenectomy (RAPS) is a superior approach for treating splenic cysts and splenic hemangiomas, as it preserves the immune function of the spleen and reduces the risk of...
2.
Zhu X, Jiao J, Xue H, Chen P, Qin C, Wang P
World J Gastrointest Surg
. 2024 Feb;
16(1):49-58.
PMID: 38328323
Background: Women have a 3% lifetime chance of developing an inguinal hernia, which is not as common in men. Due to its cosmetic benefits, single-incision laparoscopic transabdominal preperitoneal (SIL-TAPP) inguinal...
3.
Jiao J, Zhu X, Zhou C, Wang P
World J Gastrointest Surg
. 2022 Oct;
14(9):887-895.
PMID: 36185563
Cholesterol gallstones are very common in hepatobiliary surgery and have been studied to a certain extent by doctors worldwide for decades. However, the mechanism of cholesterol gallstone formation is not...
4.
Zhang J, Zhang X, Zhou Z, Zhu X, Zheng C, Li M, et al.
Evid Based Complement Alternat Med
. 2022 Apr;
2022:6097221.
PMID: 35368769
Background: Bushen Jianpi formula (BSJPF, also known as Lingmao formula) is a traditional Chinese medicine for chronic hepatitis B (CHB). The previous study has suggested that the treatment combination of...
5.
Hou Z, Zhang J, Zhang X, Ling Q, Zheng C, Zhu X, et al.
Evid Based Complement Alternat Med
. 2020 Aug;
2020:3826857.
PMID: 32831863
Objective: To evaluate the impact of long-term Traditional Chinese Medicine (TCM) syndrome differentiation combined with antiviral therapy with Nucleos (t) ide analogues (NAs) on the incidence of cirrhosis in patients...
6.
Ji L, Sun X, Zhang X, Zhou Z, Yu Z, Zhu X, et al.
J Immunol Res
. 2020 Aug;
2020:1826587.
PMID: 32766317
Helping B cells and antibody responses is a major function of CD4T helper cells. Follicular helper T (Tfh) cells are identified as a subset of CD4T helper cells, which is...
7.
Jiang P, Zhu X, Jiang R, Zhang Y, Liu L, Yang X
Am J Transl Res
. 2019 Oct;
11(9):6249-6261.
PMID: 31632591
We aimed to investigate the value of cholestasis-related miRNAs in the diagnosis of intra-hepatic cholestasis of pregnancy (ICP) as well as the molecular mechanisms underlying the role of these miRNAs...
8.
Zhang J, Zheng C, Zhu X, Zhang X, Hou Z, Zhou Z, et al.
Evid Based Complement Alternat Med
. 2019 Jul;
2019:9492034.
PMID: 31320916
To ascertain the efficacy and safety of Ganji Formulation (GF) for patients with Hepatocellular carcinoma (HCC) who had undergone surgery. A total of 262 HCC patients who had undergone liver...
9.
Ji L, Gao Q, Guo R, Zhang X, Zhou Z, Yu Z, et al.
J Immunol Res
. 2019 Feb;
2019:8983903.
PMID: 30766891
Aim: To compare the clinical efficacy of the combination therapy with Bushen formula (BSF) plus entecavir (ETV) in naïve chronic hepatitis B (CHB) patients and that in CHB patients with...
10.
Li M, Zhou Z, Bao T, Zhang X, Zhu X, Jin S, et al.
Cell Physiol Biochem
. 2018 Jul;
48(2):633-643.
PMID: 30025397
Background/aims: To investigate the clinical effects of the combination therapy with Bushen Formula (BSF) plus enticavir (ETV) on chronic hepatitis B (CHB) patients with suboptimal response to ETV and explore...